Autopsy report · NCT01238224

Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Durability of study medications could not be guaranteed after the expire date.”

The sponsor’s own words in the registry.

Life of this trial

Registered 11 months after it had already started.
Ran for about 2 years before it stopped.
22 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Vastra Gotaland Region
Sponsor type: Government (non-US federal)
Conditions: Type 2 Diabetes
Interventions: Tadalafil
Participants: 22
Sites: 1
Countries: Sweden

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.